Cross Border Alliances in the Asian Biopharmaceutical Industry

概要

論文の詳細を見る
In recent years there has been an increase in cross border alliances in the Asian biopharmaceutical industry where cost, time and innovation are of the essence. This paper studies the motivations of firms for cross border collaborations from the exploration (knowledge seeking) and exploitation (market seeking) perspectives. There are evident explorative alliances across borders that entail forming a synergy of unique and complementary assets between transnational partners, contract manufacturing and situating in optimal locations that give strength and competitive edge to the R&D, manufacturing and clinical trials part of the value creation activity as well as exploitative alliances that warrant a fast and efficient commercialization of new drugs. Included in the paper are value added case studies of how Asian biopharmaceutical firms pursue these cross border alliances to increase their market valuation and improve long-term performance.
2009-03-25